Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom
Daunorubicin 20mg Powder for I.V. Injection.
| Pharmaceutical Form |
|---|
|
Vial containing a red lyophilised powder for intravenous administration following reconstitution in Water for Injections and dilution with saline. |
Each vial contains 21.4 mg daunorubicin hydrochloride (equivalent to 20 mg as base).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Daunorubicin |
Daunorubicin is an anthracycline glycoside antibiotic and is a potent antileukaemic agent. It also has immunosuppressant effects. Daunorubicin may involve binding to DNA by intercalation between base pairs and inhibition of DNA and RNA synthesis by template disordering and steric obstruction. |
| List of Excipients |
|---|
|
Mannitol |
Glass vial with rubber cap.
Pack sizes of 1 vial and 10 vials.
Not all pack sizes may be marketed.
Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom
PL 17780/0310
8 June 1994
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
